logo

For the Inventor, By the Inventor

Ibaraki, Japan

Hiroaki Masumori

This inventor holds 5 USPTO granted patents. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1990-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroaki Masumori. Retrieved from https://idiyas.com/inventor/hiroaki-masumori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Ibaraki, JP (1990 - 1993)
  • Nishinomiya, JP (1993)

Company Filing History:

goldMedal5 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents

Years Active: 1990-1993

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5258396 - Thiazole derivatives (1993-11-02),
2. 5180731 - Aminoazole derivatives and their production and use (1993-01-19),
3. 5066666 - Aminoazole derivatives and their production and use (1991-11-19),
4. 5021435 - Certain pyridyl-thiazolidin-4-one having anti-ulcer activity (1991-06-04),
5. 4914112 - Aminoazole derivatives and their production and use (1990-04-03),

Title: Hiroaki Masumori: Innovator in Pharmaceutical Chemistry

Introduction

Hiroaki Masumori is a distinguished inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of five patents to his name, Masumori's work focuses on innovative solutions for autoimmune and inflammatory diseases.

Latest Patents

Masumori's latest patents include groundbreaking research on thiazole derivatives. These compounds are represented by a specific general formula and are designed to serve as therapeutic or preventive drugs for autoimmune diseases and inflammatory conditions. Another notable patent involves aminoazole derivatives, which also contribute to advancements in pharmaceutical applications.

Career Highlights

Throughout his career, Hiroaki Masumori has been associated with Sumitomo Pharmaceuticals Company Limited. His work has been pivotal in advancing the understanding and treatment of various medical conditions through innovative chemical compounds.

Collaborations

Masumori has collaborated with esteemed colleagues such as Atsuyuki Kojima and Yoshihiko Kimura. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Hiroaki Masumori's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patents and collaborative efforts continue to pave the way for new treatments that address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…